Latest Articles
Boost for women as Chinese scientists identify key target for treating adenomyosis - qazinform.com
Boost for women as Chinese scientists identify key target for treating adenomyosis qazinform.com
Published: Aug. 20, 2025, 2:35 p.m.
China Focus: Boost for women as Chinese scientists identify key target for treating adenomyosis - Xinhua
China Focus: Boost for women as Chinese scientists identify key target for treating adenomyosis Xinhua
Published: Aug. 20, 2025, 8:59 a.m.
Single-cell RNA sequencing identifies the prolactin receptor as a therapeutic target in adenomyosis - Nature
Single-cell RNA sequencing identifies the prolactin receptor as a therapeutic target in adenomyosis Nature
Published: Aug. 13, 2025, 2:22 p.m.
Will a bounce in IGMS offer an exit [2025 Price Targets] - Free Reliable Volume Spike Trade Alerts - Newser
Will a bounce in IGMS offer an exit [2025 Price Targets] - Free Reliable Volume Spike Trade Alerts Newser
Published: Aug. 13, 2025, 4:23 a.m.
Rachel Zegler Is an ‘Easy Target’, Says Evita Co-Star Amid Snow White Controversy - SKJ Bollywood News
Rachel Zegler Is an ‘Easy Target’, Says Evita Co-Star Amid Snow White Controversy SKJ Bollywood News
Published: Aug. 5, 2025, 1:56 p.m.
New therapeutic targets for endometriosis predicted through Mendelian randomization analysis and case-control trials - Frontiers
New therapeutic targets for endometriosis predicted through Mendelian randomization analysis and case-control trials Frontiers
Published: Aug. 4, 2025, 8:01 a.m.
Support Tere: Journey started with endometriosis but now battling Stage 4 metastatic cancer targeting her liver and lymph nodes - Givealittle
Support Tere: Journey started with endometriosis but now battling Stage 4 metastatic cancer targeting her liver and lymph nodes Givealittle
Published: Aug. 1, 2025, 10:56 p.m.
Neuroinflammation is responsible for pain in endometriosis -Targeting the JAK-STAT Pathway and Mast Cell Activation - Frontiers
Neuroinflammation is responsible for pain in endometriosis -Targeting the JAK-STAT Pathway and Mast Cell Activation Frontiers
Published: July 31, 2025, 8:44 p.m.
Onconic Therapeutics announced on the 28th that "Nesuparib," a candidate for a double-targeted antic.. - 매일경제
Onconic Therapeutics announced on the 28th that "Nesuparib," a candidate for a double-targeted antic.. 매일경제
Published: July 28, 2025, 6:56 a.m.
B7-H4 Targeting Therapies Market Growth Set to Accelerate Across the 7MM During the Study Period (2025-2040) with Advances in Immunotherapy | DelveInsight - The Malaysian Reserve
B7-H4 Targeting Therapies Market Growth Set to Accelerate Across the 7MM During the Study Period (2025-2040) with Advances in Immunotherapy | DelveInsight The Malaysian Reserve
Published: July 24, 2025, 10:55 p.m.
Link copied to clipboard!